Wednesday, October 04, 2017 8:06:19 AM
All of these may likely be true (well, except September has passed) - however, anticipation of future results was the impetus for the early wave of this current valuation. Much of that anticipation purchased in early and either held or moved on.
Currently, more predictions will not move share price to a significant degree. Now is the part of the business plan where predictions must turn into results in order for company value to increase.
The market doesn't want more predictions, they want results.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM